These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 17120363

  • 1. Low-down on link between bone-builders and jaw damage.
    Johns Hopkins Med Lett Health After 50; 2006 Sep; 18(7):1-2. PubMed ID: 17120363
    [No Abstract] [Full Text] [Related]

  • 2. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L, Masood F.
    J Okla Dent Assoc; 2008 Sep; 99(7):28-9. PubMed ID: 18595621
    [Abstract] [Full Text] [Related]

  • 3. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P, Skoglund LA, Skjelbred P.
    Tidsskr Nor Laegeforen; 2007 Aug 09; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract] [Full Text] [Related]

  • 4. Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants.
    Garg AK.
    Dent Implantol Update; 2006 Oct 09; 17(10):73-8. PubMed ID: 17066981
    [No Abstract] [Full Text] [Related]

  • 5. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
    Bamias A, Terpos E, Dimopoulos MA.
    Onkologie; 2010 Oct 09; 33(6):288-9. PubMed ID: 20523090
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Specialists play down risk of jaw condition.
    Stassen LF.
    J Ir Dent Assoc; 2008 Oct 09; 54(4):153. PubMed ID: 18780680
    [No Abstract] [Full Text] [Related]

  • 8. Osteonecrosis of the jaw.
    Sykes DL.
    Dent Today; 2007 Feb 09; 26(2):16. PubMed ID: 17348272
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Do Fosamax-type drugs increase the risk of osteonecrosis of the jaw for patients receiving dental implants?
    Wynn RL.
    Gen Dent; 2008 Feb 09; 56(5):410-1. PubMed ID: 18683394
    [No Abstract] [Full Text] [Related]

  • 11. Standard protocols.
    Kini G.
    Br Dent J; 2007 Oct 27; 203(8):440. PubMed ID: 17965662
    [No Abstract] [Full Text] [Related]

  • 12. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
    Geist RY, Geist JR, Aksu M.
    J Mich Dent Assoc; 2005 Nov 27; 87(11):40-2. PubMed ID: 16372547
    [No Abstract] [Full Text] [Related]

  • 13. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.
    Marx RE.
    Int J Periodontics Restorative Dent; 2008 Feb 27; 28(1):5-6. PubMed ID: 18351197
    [No Abstract] [Full Text] [Related]

  • 14. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL.
    Gen Dent; 2007 Feb 27; 55(1):8-10. PubMed ID: 17333956
    [No Abstract] [Full Text] [Related]

  • 15. Bisphosphonates and bone...what have we learned?
    Guttenberg SA.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec 27; 106(6):769-72. PubMed ID: 18835534
    [No Abstract] [Full Text] [Related]

  • 16. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O, Ozet A, Ataergin S, Kuzhan O, Arpaci F, Ozturk B, Komurcu S, Ozturk M.
    Oral Dis; 2007 May 27; 13(3):346-7. PubMed ID: 17448221
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An unavoidable and unmistakable link.
    Rossi MS.
    N Y State Dent J; 2006 May 27; 72(5):6-8. PubMed ID: 17036580
    [No Abstract] [Full Text] [Related]

  • 19. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V, Baraldi A, Loidoris A, Ciuffreda L, Galassi C, Goia F, Scoletta M, Berrone S, Benech A, Ortega C, Berruti A, Rete Oncologia di Piemonte e Valle d'Aosta ONJ Study Group.
    J Oral Maxillofac Surg; 2009 Aug 27; 67(8):1775. PubMed ID: 19615599
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.